Benzinga's Microcap Movers for Tuesday March 20, 2012
Below are highlights from Benzinga's daily coverage of microcap securities making big moves:
Shares of Rosetta Genomics (NASDAQ: ROSG), the Israeli developer and provider of microRNA-based molecular diagnostics, rose 81% Tuesday on 7 times the average daily volume.
Rosetta Genomics announced Tuesday that data from a study investigating the ability of microRNA expression to determine the risk of disease recurrence in colorectal cancer patients was published in the online edition of the International Journal of Oncology and is expected to appear in the upcoming print edition.
The study compared the microRNA profiles in the primary tumor of patients with recurrent and non-recurrent colorectal cancer. The study included 110 patients, 51 (46%) with stage I and 59 (54%) with stage II disease, who underwent curative colectomies without adjuvant therapy and for whom reliable miRNA expression data was available. RNA was extracted from formalin-fixed paraffin-embedded tumor samples. Initial profiling, using microarrays, was done to identify potential biomarkers of recurrence.
Commenting on these data, study collaborator, Baruch Brenner, M.D., Institute of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Hospital and Sackler Faculty of Medicine, Tel Aviv University, both in Israel, noted, "The risk of recurrence following successful complete resection is high in stage II and III disease. Consequently, most of these patients will receive additional treatment including postoperative chemotherapy and preoperative or postoperative chemo-radiotherapy. However, the majority of patients receiving neoadjuvant and/or adjuvant therapy, which are associated with significant morbidity and even long-term sequelae and mortality, do not need it."
Rosetta Genomics closed at $0.58 on Tuesday.
Shares of NewLead Holdings (NASDAQ: NEWL), the Greek shipping company, rose 36% Tuesday on 12 times the average daily volume.
NewLead Holdings announced Monday that the Company's Board of Directors decided to cancel the 1-for-5 reverse stock split of its common shares that was scheduled to take effect upon the opening of the NASDAQ market on March 19, 2012, with a view to rectifying the minimum bid listing deficiency as previously announced.
Shares soared when the stock resumed trading Tuesday morning.
NewLead Holdings closed at $1.70 on Tuesday.
Shares of DHT Holdings (NYSE: DHT), the Channel Islands operator of crude oil tankers, fell 26% Tuesday on 5 times the average daily volume.
DHT Holdings announced Monday an offering of 51.8 million shares and will use the proceeds to repay debt. DHT currently owns a fleet of 12 tankers.
DHT Holdings closed at $1.09 on Tuesday.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.